Arcus Biosciences (RCUS) Non Operating Income (2017 - 2026)

Arcus Biosciences' Non Operating Income history runs 10 years deep, the most recent figure standing at $6.0 million for Q1 2026.

• In Q1 2026, Non Operating Income fell 40.0% year-over-year to $6.0 million; the TTM figure through Mar 2026 stood at $29.0 million (down 36.96% YoY), while the FY2025 annual figure was $33.0 million, down 31.25% from the prior year.
• Non Operating Income was $6.0 million for Q1 2026 at Arcus Biosciences, down from $8.0 million in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $13.0 million in Q2 2024 to a low of $191000.0 in Q1 2022.
• Historically, Non Operating Income has averaged $8.2 million across 5 years, with a median of $8.0 million in 2023.
• The sharpest annual moves came in 2023 and 2025: Non Operating Income soared 4088.48% in 2023, then tumbled 46.15% in 2025.
• A 5-year view of Non Operating Income shows it stood at $7.0 million in 2022, then surged by 57.14% to $11.0 million in 2023, then declined by 9.09% to $10.0 million in 2024, then dropped by 20.0% to $8.0 million in 2025, then decreased by 25.0% to $6.0 million in 2026.
• The last three Non Operating Income figures came in at $6.0 million (Q1 2026), $8.0 million (Q4 2025), and $7.0 million (Q3 2025), per Business Quant data.